Home › NDC Lookup › Labelers › U.s. Pharmaceuticals

U.s. Pharmaceuticals NDCs and Package Codes

This page lists NDC package records associated with labeler code 63539 (U.s. Pharmaceuticals) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

23
Package NDCs
46
Products
45
Active listings
1
Discontinued
11
Ingredients
0
Therapeutic classes
7
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
tofacitinib 15
abrocitinib 12
palbociclib 6
talazoparib 4
axitinib 2
conjugated estrogens/bazedoxifene 2
zavegepant 1
Bosutinib 1
elranatamab-bcmm 1
ritlecitinib 1
By dosage form
TABLET, FILM COATED 30
TABLET, EXTENDED RELEASE 6
SOLUTION 3
CAPSULE 3
CAPSULE, LIQUID FILLED 2
SPRAY 1
INJECTION, SOLUTION 1

Browse records — 46 products

Drug / product Billing NDC NADAC / unit Status
BOSULIF Bosutinib 400 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0193-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63539-193-30) 63539-0193-30 — FDA-listed View →
CIBINQO abrocitinib 200 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0436-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-436-14) 63539-0436-14 — FDA-listed View →
CIBINQO abrocitinib 50 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0236-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-236-14) 63539-0236-14 — FDA-listed View →
CIBINQO abrocitinib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0336-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14) 63539-0336-14 — FDA-listed View →
CIBINQO abrocitinib 50 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0236-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-236-14) 63539-0236-14 — FDA-listed View →
CIBINQO abrocitinib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0336-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14) 63539-0336-14 — FDA-listed View →
CIBINQO abrocitinib 200 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0436-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-436-14) 63539-0436-14 — FDA-listed View →
CIBINQO abrocitinib 50 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0236-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-236-14) 63539-0236-14 — FDA-listed View →
CIBINQO abrocitinib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0336-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14) 63539-0336-14 — FDA-listed View →
CIBINQO abrocitinib 200 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0436-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-436-14) 63539-0436-14 — FDA-listed View →
CIBINQO abrocitinib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0336-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14) 63539-0336-14 — FDA-listed View →
CIBINQO abrocitinib 200 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0436-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-436-14) 63539-0436-14 — FDA-listed View →
CIBINQO abrocitinib 50 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0236-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-236-14) 63539-0236-14 — FDA-listed View →
Duavee conjugated estrogens/bazedoxifene .45 mg/1; 20 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0122-07 · 1 BLISTER PACK in 1 CARTON (63539-122-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK 63539-0122-07 — FDA-listed View →
Duavee conjugated estrogens/bazedoxifene .45 mg/1; 20 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0122-07 · 1 BLISTER PACK in 1 CARTON (63539-122-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK 63539-0122-07 — FDA-listed View →
Elrexfio elranatamab-bcmm 44 mg/1.1mL INJECTION, SOLUTION U.S. · NDC 63539-0252-02 · 1 VIAL, SINGLE-DOSE in 1 CARTON (63539-252-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (63539-252-01) 63539-0252-02 — FDA-listed View →
Ibrance palbociclib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0486-03 · 3 DOSE PACK in 1 CARTON (63539-486-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-486-07) 63539-0486-03 — FDA-listed View →
Ibrance palbociclib 75 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0284-03 · 3 DOSE PACK in 1 CARTON (63539-284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-284-07) 63539-0284-03 — FDA-listed View →
Ibrance palbociclib 125 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0688-03 · 3 DOSE PACK in 1 CARTON (63539-688-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-688-07) 63539-0688-03 — FDA-listed View →
Ibrance palbociclib 125 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0688-03 · 3 DOSE PACK in 1 CARTON (63539-688-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-688-07) 63539-0688-03 — FDA-listed View →
Ibrance palbociclib 75 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0284-03 · 3 DOSE PACK in 1 CARTON (63539-284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-284-07) 63539-0284-03 — FDA-listed View →
Ibrance palbociclib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0486-03 · 3 DOSE PACK in 1 CARTON (63539-486-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-486-07) 63539-0486-03 — FDA-listed View →
INLYTA axitinib 1 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0026-01 · 90 TABLET, FILM COATED in 1 BOTTLE (63539-026-01) 63539-0026-01 — FDA-listed View →
INLYTA axitinib 5 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0044-01 · 60 TABLET, FILM COATED in 1 BOTTLE (63539-044-01) 63539-0044-01 — Discontinued View →
Litfulo ritlecitinib 50 mg/1 CAPSULE U.S. · NDC 63539-0334-28 · 28 CAPSULE in 1 BOTTLE (63539-334-28) 63539-0334-28 — FDA-listed View →
Lorbrena lorlatinib 25 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0927-01 · 30 TABLET, FILM COATED in 1 BOTTLE (63539-927-01) 63539-0927-01 — FDA-listed View →
Talzenna talazoparib .5 mg/1 CAPSULE, LIQUID FILLED U.S. · NDC 63539-0025-30 · 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (63539-025-30) 63539-0025-30 — FDA-listed View →
Talzenna talazoparib 1 mg/1 CAPSULE U.S. · NDC 63539-0295-30 · 1 BOTTLE in 1 CARTON (63539-295-30) / 30 CAPSULE in 1 BOTTLE 63539-0295-30 — FDA-listed View →
Talzenna talazoparib 1 mg/1 CAPSULE, LIQUID FILLED U.S. · NDC 63539-0031-30 · 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (63539-031-30) 63539-0031-30 — FDA-listed View →
Talzenna talazoparib .5 mg/1 CAPSULE U.S. · NDC 63539-0051-30 · 1 BOTTLE in 1 CARTON (63539-051-30) / 30 CAPSULE in 1 BOTTLE 63539-0051-30 — Discontinued View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.